Express Pharma
Home  »  Archive  »  Merck Serono appoints Meeta Gulyani as Head of Strategy and Global Franchises

Merck Serono appoints Meeta Gulyani as Head of Strategy and Global Franchises

0 21

Merck Serono announced the appointment of Meeta Gulyani to the position of head of strategy and Global Franchises as of May 7, 2014. Gulyani will be based in Boston (United States) and will report to Belén Garijo, President and Chief Executive Officer of Merck Serono.

“I am very pleased to have Meeta on board as we are moving into a new phase of Merck Serono’s transformation, focused on growth, and seek to maximise the value of our current product portfolio and build our future product offering”, said Belén Garijo, President and Chief Executive Chief Executive Officer of Merck Serono. “Meeta is an accomplished executive with a leadership track record across strategic and operational roles in both mature and emerging markets and will bring the necessary expertise and global perspective required for this important role.”

Gulyani will be leading Merck Serono’s global franchises (Multiple sclerosis and immunology, oncology, fertility, general medicine and endocrinology, and medical devices), with a strong focus on defining integrated strategies for the different disease areas, ensuring rigorous allocation of resources in line with the strategy, as well supporting drive Merck Serono’s operating performance through marketing excellence. With Meeta Gulyani’s appointment, and further to the promotion of Elcin Ergun on January 1, 2014 as head of commercial, Merck Serono’s Pharmaceutical executive committee is now complete.

Merck Serono has been strengthening its global management to compete with innovative drugs in mature markets such as Europe and North America as well as respond to rising medical needs in emerging markets, which already accounted for almost one third of the division’s €5.96 billion sales in 2013.

Gulyani joins Merck Serono from Roche where she was most recently general manager for South Asia, covering India, Sri Lanka, Bangladesh and Nepal, and previously Vice President of Global Portfolio Management. Prior to joining Roche in 2010, Gulyani spent eight years at Sanofi. She holds an MBA from the Asian Institute of Management, Philippines, accompanied by an exchange programme at Wharton, University of Pennsylvania, US, and a BA in Economics from the Shri Ram College of Commerce from the Delhi University, India.

EP News BureauMumbai

Leave A Reply

Your email address will not be published.